Supernus Pharmaceuticals
SUPN
SUPN
292 hedge funds and large institutions have $2.15B invested in Supernus Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 101 increasing their positions, 96 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
292
Holders Change
+22
Holders Change %
+8.15%
% of All Funds
3.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
43
Increased
101
Reduced
96
Closed
20
Calls
$994K
Puts
$235K
Net Calls
+$759K
Net Calls Change
+$132K
Top Buyers
| 1 |
WP
Woodline Partners
San Francisco,
California
|
+$8.51M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$7.54M |
| 3 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$6.13M |
| 4 |
D.E. Shaw & Co
New York
|
+$4.95M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$4.56M |
